LANG PETER FREDERICK (Chief Financial Officer) reported 1 transaction at AERIE PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 11/21/2022ACC: 0001209191-22-058183
Officer· Chief Financial Officer
Since Mar 2022
-206.85K
Net shares
Net seller
$706.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
206.85K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−46.30K
Price / share
$15.25
Trade value
$706.03K
% of position
New position
11/21/2022
46.30K→0.00
Total
Net shares
−46.30K
Net value
-$706.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2022 | D · Disposition | −46.30K | $15.25 | $706.03K | New position | 46.30K | 0.00 |
| Total | −46.30K | -$706.03K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
160.55K shares
Shares
−160.55K
Strike price
8.80
Held after
0.00
Exercisable
—
11/21/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock160.55K shares | 11/21/2022 | D · Disposition | −160.55K | 8.80 | — | 0.00 |